|
WDR70 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.612800E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67288999999293E-05 |
| Normal-vs-Stage2 |
3.781200E-01 |
| Normal-vs-Stage3 |
2.961600E-01 |
| Normal-vs-Stage4 |
1.022630E-01 |
| Stage1-vs-Stage2 |
4.615600E-02 |
| Stage1-vs-Stage3 |
2.617600E-03 |
| Stage1-vs-Stage4 |
6.477900E-02 |
| Stage2-vs-Stage3 |
8.695200E-01 |
| Stage2-vs-Stage4 |
6.962000E-01 |
| Stage3-vs-Stage4 |
4.808200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.417380E-03 |
| Normal-vs-AfricanAmerican |
6.906400E-02 |
| Normal-vs-Asian |
3.974400E-02 |
| Caucasian-vs-AfricanAmerican |
9.508200E-01 |
| Caucasian-vs-Asian |
5.468200E-01 |
| AfricanAmerican-vs-Asian |
6.071400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.677060E-03 |
| Normal-vs-Female |
5.075800E-03 |
| Male-vs-Female |
8.670600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.976200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.380240E-02 |
| Normal-vs-Age(61-80Yrs) |
1.374980E-04 |
| Normal-vs-Age(81-100Yrs) |
2.595000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.789800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.624050E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.628580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.689700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.273400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.481600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.48669999999685E-05 |
| Normal-vs-Grade 2 |
1.96733999999754E-05 |
| Normal-vs-Grade 3 |
3.059700E-02 |
| Normal-vs-Grade 4 |
7.394600E-01 |
| Grade 1-vs-Grade 2 |
2.009200E-01 |
| Grade 1-vs-Grade 3 |
3.265700E-02 |
| Grade 1-vs-Grade 4 |
5.499700E-03 |
| Grade 2-vs-Grade 3 |
1.959990E-02 |
| Grade 2-vs-Grade 4 |
2.236200E-03 |
| Grade 3-vs-Grade 4 |
1.663040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.79860000004695E-06 |
| Normal-vs-ccB subtype |
5.474000E-01 |
| ccA subtype-vs-ccB subtype |
2.06309999999377E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.664440E-03 |
| Normal-vs-N1 |
8.972600E-01 |
| N0-vs-N1 |
1.794790E-01 |
|
|
